Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

IMAGION BIOSYSTEMS LIMITED

INVESTOR PRESENTATION - IMAGION BIOSYSTEMS LIMITED

ASX:IBX

IMAGION BIOSYSTEMS LIMITED

Health Care

Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.

Read more

Market Cap

70.73m

Price at Close

$0.078

4w avg. Volume

5.88m

4w avg. Turnover

$466.49k

Announcements
announcementt+2 movementdate
  • Cleansing Notice Under Section 708A

    Issued Capital

  • -

    20 Oct 2020

-

20 Oct 2020
  • Appendix 2A - Fully Paid Ordinary Shares

    Issued Capital

  • -

    20 Oct 2020

-

20 Oct 2020
  • Imagion appoints Geoff Hollis as CFO

    Company Administration

  • -

    18 Oct 2020

-

18 Oct 2020
  • Imagion announces HREC approval for Phase I study

    Progress Report · Market sensitive

  • 0.00%

    06 Oct 2020

0.00%

06 Oct 2020
  • Issue of Unlisted Performance Options under EIP

    Issued Capital

  • +5.19%

    05 Oct 2020

+5.19%

05 Oct 2020
  • Appendix 3G

    Issued Capital

  • +5.19%

    05 Oct 2020

+5.19%

05 Oct 2020
  • Cleansing Notice Under Section 708A

    Issued Capital

  • -2.56%

    22 Sep 2020

-2.56%

22 Sep 2020
  • Appendix 2A - Fully Paid Ordinary Shares

    Issued Capital

  • -2.56%

    22 Sep 2020

-2.56%

22 Sep 2020
  • Change of Director's Interest Notice - Robert Proulx

    Shareholder Details

  • -2.17%

    10 Sep 2020

-2.17%

10 Sep 2020
  • Appendix 2A - Fully Paid Ordinary Shares

    Issued Capital

  • -2.17%

    10 Sep 2020

-2.17%

10 Sep 2020
Market Data

Current Price

$0.078

52WK HIGH

$0.11

52WK LOW

$0.01

1YR RETURN

+95.00%

1YR RETURN VS. SECTOR

+47.47%

90 DAY RETURN

+25.81%

ASX RANK

925

/2,008

SECTOR RANK

13

/28

SHARES OUTSTANDING

906.82m
ASX:IBX

IMAGION BIOSYSTEMS LIMITED

Health Care

Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.

Read more

Market Cap

70.73m

Price at Close

$0.078

4w avg. Volume

5.88m

4w avg. Turnover

$466.49k

ASX:IBX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.